Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Genome-wide DNA methylation analysis of transient neonatal diabetes type 1 patients with mutations in ZFP57

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Case report a novel KERA mutation associated with cornea plana and its predicted effect on protein function

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Genetic disease is a common cause of bilateral childhood cataract in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Clinical and molecular delineation of PUS3-associated neurodevelopmental disorders

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Clinical utility gene card for oculocutaneous (OCA) and ocular albinism (OA)-an update

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. ZMYND11 variants are a novel cause of centrotemporal and generalised epilepsies with neurodevelopmental disorder

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Classification of MSH6 Variants of Uncertain Significance Using Functional Assays

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

BACKGROUND: Transient neonatal diabetes mellitus 1 (TNDM1) is a rare imprinting disorder characterized by intrautering growth retardation and diabetes mellitus usually presenting within the first six weeks of life and resolves by the age of 18 months. However, patients have an increased risk of developing diabetes mellitus type 2 later in life. Transient neonatal diabetes mellitus 1 is caused by overexpression of the maternally imprinted genes PLAGL1 and HYMAI on chromosome 6q24. One of the mechanisms leading to overexpression of the locus is hypomethylation of the maternal allele of PLAGL1 and HYMAI. A subset of patients with maternal hypomethylation at PLAGL1 have hypomethylation at additional imprinted loci throughout the genome, including GRB10, ZIM2 (PEG3), MEST (PEG1), KCNQ1OT1 and NESPAS (GNAS-AS1). About half of the TNDM1 patients carry mutations in ZFP57, a transcription factor involved in establishment and maintenance of methylation of imprinted loci. Our objective was to investigate whether additional regions are aberrantly methylated in ZFP57 mutation carriers.

METHODS: Genome-wide DNA methylation analysis was performed on four individuals with homozygous or compound heterozygous ZFP57 mutations, three relatives with heterozygous ZFP57 mutations and five controls. Methylation status of selected regions showing aberrant methylation in the patients was verified using bisulfite-sequencing.

RESULTS: We found large variability among the patients concerning the number and identity of the differentially methylated regions, but more than 60 regions were aberrantly methylated in two or more patients and a novel region within PPP1R13L was found to be hypomethylated in all the patients. The hypomethylated regions in common between the patients are enriched for the ZFP57 DNA binding motif.

CONCLUSIONS: We have expanded the epimutational spectrum of TNDM1 associated with ZFP57 mutations and found one novel region within PPP1R13L which is hypomethylated in all TNDM1 patients included in this study. Functional studies of the locus might provide further insight into the etiology of the disease.

Original languageEnglish
JournalBMC Medical Genetics
Volume17
Pages (from-to)29
DOIs
Publication statusPublished - 2016

    Research areas

  • Alleles, Case-Control Studies, DNA Methylation, DNA-Binding Proteins, Diabetes Mellitus, Genetic Loci, Genomic Imprinting, Homozygote, Humans, Infant, Infant, Newborn, Diseases, Intracellular Signaling Peptides and Proteins, Repressor Proteins, Reproducibility of Results, Sequence Analysis, DNA, Transcription Factors

ID: 46437662